Overall Status

Recruiting (2)

Active, not recruiting (1)

Phase

n/a (1)

phase 2 (1)

phase 3 (1)

Sponsor

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

University of California, San Francisco (1)

Collaborator

National Cancer Institute (NCI) (1)

Varian Medical Systems (1)

Intervention

carboplatin (1)

dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine medi0457 (1)

durvalumab (1)

nivolumab (1)

paclitaxel (1)

radiation therapy (rt) (1)

Study Documents

Intervention Type

biological (2)

drug (1)

radiation (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

stage iv anal cancer ajcc v8

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Metastatic Anal Squamous Cell Carcinoma Trial in United States

Recruiting

Anal Basaloid Carcinoma
+6 more

Carboplatin
+2 more

Anchorage, Alaska
+545 more

Jan 28, 2023

Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer Trial in San Francisco

Recruiting

Stage IV Esophageal Adenocarcinoma
+43 more

Radiation Therapy (RT)

San Francisco, California

University of California, San Francisco

Mar 29, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting

Human Papillomavirus-16 Positive
+20 more

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
Durvalumab

Houston, Texas

M D Anderson Cancer Center

Feb 11, 2022